{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:57:53Z","timestamp":1792799873192,"version":"4.5.0"},"reference-count":531,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10,1]]},"DOI":"10.1210\/er.2015-1104","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T13:00:47Z","timestamp":1469538047000},"page":"467-520","source":"Crossref","is-referenced-by-count":1390,"title":["The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited"],"prefix":"10.1210","volume":"37","author":[{"given":"Robert L.","family":"Rosenfield","sequence":"first","affiliation":[{"name":"Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism, The University of Chicago Pritzker School of Medicine, Chicago, Illinois 60637"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Ehrmann","sequence":"additional","affiliation":[{"name":"Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism, The University of Chicago Pritzker School of Medicine, Chicago, Illinois 60637"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"2019041121525531100_B1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/humrep\/det469","article-title":"The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone","volume":"29","author":"Lauritsen","year":"2014","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121525531100_B4","doi-asserted-by":"crossref","first-page":"247.e1","DOI":"10.1016\/j.ajog.2015.12.013","article-title":"Stein and Leventhal: 80 years on","volume":"214","author":"Azziz","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121525531100_B5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/jcem-22-3-325","article-title":"The polycystic ovary. I. Clinical and histologic features","volume":"22","author":"Goldzieher","year":"1962","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B6","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1210\/jcem-18-11-1202","article-title":"The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system","volume":"18","author":"McArthur","year":"1958","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1210\/jcem-30-4-435","article-title":"Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease","volume":"30","author":"Yen","year":"1970","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1210\/jcem-34-1-92","article-title":"Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women","volume":"34","author":"Rosenfield","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem-62-1-16","article-title":"Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals","volume":"62","author":"Futterweit","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.1989.tb00457.x","article-title":"Polycystic ovary syndrome: a changing perspective","volume":"31","author":"Franks","year":"1989","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(83)90091-1","article-title":"Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features","volume":"147","author":"Barbieri","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121525531100_B12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovary disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B13","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"2019041121525531100_B14","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1210\/jcem-62-5-904","article-title":"Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism","author":"Barbieri","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B15","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1210\/endo-122-5-2034","article-title":"Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: cellular mechanism (s) underlying physiological and pharmacological hormonal actions","volume":"122","author":"Hernandez","year":"1988","journal-title":"Endocrinology"},{"key":"2019041121525531100_B16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1210\/endo-123-2-733","article-title":"Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian theca-interstitial cells","volume":"123","author":"Cara","year":"1988","journal-title":"Endocrinology"},{"key":"2019041121525531100_B17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198903023200904","article-title":"Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome","volume":"320","author":"Barnes","year":"1989","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0015-0282(16)53510-9","article-title":"Dysregulation of cytochrome P450c 17\u03b1 as the cause of polycystic ovary syndrome","volume":"53","author":"Rosenfield","year":"1990","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B20","first-page":"83","article-title":"Ovarian steroidogenic abnormalities in polycystic ovary syndrome: evidence for abnormal coordinate regulation of androgen and estrogen secretion","volume-title":"Polycystic Ovary Syndrome","author":"Rosenfield","year":"1992"},{"key":"2019041121525531100_B21","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","volume-title":"Polycystic Ovary Syndrome","author":"Zawadzki","year":"1992"},{"key":"2019041121525531100_B22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B23","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"2019041121525531100_B24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2008-1492","article-title":"Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance","volume":"94","author":"Ciaraldi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db13-1514","article-title":"Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell","volume":"63","author":"Wu","year":"2014","journal-title":"Diabetes"},{"key":"2019041121525531100_B26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"2019041121525531100_B27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B29","unstructured":"Johnson T , KaplanL, OuyangP, RizzaR. National Institutes of Health evidence-based methodology workshop on polycystic ovary syndrome (PCOS). NIH EbMW Report. 2013. Available from https:\/\/prevention.nih.gov\/programs-events\/pathways-to-prevention\/previous-workshops\/pcos\/workshop-resources. Bethesda, MD: National Institutes of Health; 1\u201314."},{"key":"2019041121525531100_B30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpag.2014.07.016","article-title":"The polycystic ovary morphology-polycystic ovary syndrome spectrum","volume":"28","author":"Rosenfield","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2019041121525531100_B31","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2003-031600","article-title":"Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome","volume":"89","author":"Adams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B33","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","article-title":"Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes","volume":"94","author":"Guastella","year":"2010","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B34","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/1933719114522525","article-title":"Prevalence of polycystic ovary syndrome phenotypes using updated criteria for polycystic ovarian morphology: an assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome","volume":"21","author":"Clark","year":"2014","journal-title":"Reprod Sci"},{"key":"2019041121525531100_B35","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.02.020","article-title":"Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations","volume":"101","author":"Ladron de Guevara","year":"2014","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.fertnstert.2014.12.094","article-title":"Ultrasound features of polycystic ovaries relate to degree of reproductive and metabolic disturbance in polycystic ovary syndrome","volume":"103","author":"Christ","year":"2015","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/1933719115611751","article-title":"The role of anti-M\u00fcllerian hormone in the characterization of the different polycystic ovary syndrome phenotypes","volume":"23","author":"Romualdi","year":"2015","journal-title":"Reprod Sci"},{"key":"2019041121525531100_B38","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/jc.2007-2437","article-title":"Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrin Metab"},{"key":"2019041121525531100_B39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2012.03.059","article-title":"Antim\u00fcllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries","volume":"98","author":"Rosenfield","year":"2012","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/cen.12621","article-title":"Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?","volume":"82","author":"Lauritsen","year":"2015","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B41","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1056\/NEJMcp033496","article-title":"Clinical practice. Hirsutism [comment appears in N Engl J Med. 2006;354(14):1533\u20131535; author reply 1533\u20131535]","volume":"353","author":"Rosenfield","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B42","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1210\/jc.2013-1770","article-title":"Clinical review: adolescent anovulation: maturational mechanisms and implications","volume":"98","author":"Rosenfield","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B43","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2010-1314","article-title":"Toward excellence in testosterone testing: a consensus statement","volume":"95","author":"Rosner","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B44","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1210\/en.2014-7534","article-title":"Steroid assays and endocrinology: best practices for basic scientists","volume":"155","author":"Auchus","year":"2014","journal-title":"Endocrinology"},{"key":"2019041121525531100_B45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B46","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1210\/jc.2010-1123","article-title":"Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism","volume":"95","author":"Legro","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B47","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B48","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.fertnstert.2013.12.056","article-title":"Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria","volume":"101","author":"Salameh","year":"2014","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B49","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2019041121525531100_B50","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1542\/peds.2015-1430","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"136","author":"Rosenfield","year":"2015","journal-title":"Pediatrics"},{"key":"2019041121525531100_B51","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000375530","article-title":"The diagnosis of polycystic ovary syndrome during adolescence","volume":"83","author":"Witchel","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"2019041121525531100_B52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/JPEM.2007.20.1.41","article-title":"Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome","volume":"20","author":"Littlejohn","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019041121525531100_B53","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1210\/jc.2014-4290","article-title":"Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood","volume":"100","author":"Rosenfield","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(99)00641-X","article-title":"Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome","volume":"73","author":"Winters","year":"2000","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B55","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1365-2265.2001.01412.x","article-title":"Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome","volume":"55","author":"Elting","year":"2001","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/dmm020","article-title":"A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project","volume":"13","author":"Burger","year":"2007","journal-title":"Hum Reprod Update"},{"key":"2019041121525531100_B57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B58","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1210\/jcem-26-11-1267","article-title":"Androstenedione and testosterone in ovarian venous and peripheral plasma during ovariectomy for breast cancer","volume":"26","author":"Horton","year":"1966","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI105344","article-title":"Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone","volume":"45","author":"Horton","year":"1966","journal-title":"J Clin Invest"},{"key":"2019041121525531100_B60","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0026-0495(72)90090-X","article-title":"Androgen production and metabolism in normal and virilized women","volume":"21","author":"Kirschner","year":"1972","journal-title":"Metabolism"},{"key":"2019041121525531100_B61","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1210\/en.2007-0248","article-title":"Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility","volume":"148","author":"Walters","year":"2007","journal-title":"Endocrinology"},{"key":"2019041121525531100_B62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B63","first-page":"4122","article-title":"Expression of steroidogenic acute regulatory protein (StAR) in the human ovary","volume":"81","author":"Kiriakidou","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.mce.2014.09.010","article-title":"The post-translational regulation of 17,20 lyase activity","volume":"408","author":"Miller","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121525531100_B65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/mend-1-9-595","article-title":"Noncoordinate regulation of de novo synthesis of cytochrome P-450 cholesterol side-chain cleavage and cytochrome P-450 17\u03b1-hydroxylase\/C17\u201320 lyase in mouse Leydig cell cultures: relation to steroid production","volume":"1","author":"Anakwe","year":"1987","journal-title":"Mol Endocrinol"},{"key":"2019041121525531100_B66","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1210\/endo-125-3-1464","article-title":"Evidence that luteinizing hormone-stimulated differentiation of purified ovarian thecal-interstitial cells is mediated by both type I and type II adenosine 3\u2032,5\u2032-monophosphate-dependent protein kinases","volume":"125","author":"Magoffin","year":"1989","journal-title":"Endocrinology"},{"key":"2019041121525531100_B67","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1073\/pnas.83.13.4715","article-title":"Transcriptional regulation of steroid hydroxylase genes by corticotropin","volume":"83","author":"John","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121525531100_B68","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/jcem-65-1-170","article-title":"Hormonal regulation of messenger ribonucleic acids for P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17 \u03b1-hydroxylase\/17,20 lyase) in cultured human fetal adrenal cells","volume":"65","author":"Di Blasio","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1530\/acta.0.0370019","article-title":"In vitro production of testosterone and androst-4-ene-3,17-dione in a human ovarian homogenate","volume":"37","author":"Kase","year":"1961","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121525531100_B70","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1210\/jcem-22-4-431","article-title":"The polycystic ovary. III. Steroid biosynthesis in normal and polycystic ovarian tissue","volume":"22","author":"Axelrod","year":"1962","journal-title":"J Clin Endocrinol"},{"key":"2019041121525531100_B71","first-page":"251","article-title":"Androgen biosynthesis and related studies","volume":"19","author":"Dorfman","year":"1963","journal-title":"Rec Prog Horm Res"},{"key":"2019041121525531100_B72","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/jcem-67-2-379","article-title":"Androgen and estrogen dynamics in pre- and postmenopausal women: a comparison between smokers and nonsmokers","volume":"67","author":"Longcope","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B74","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0039-128X(80)90074-4","article-title":"Substrate specificity of the placental microsomal aromatase","volume":"36","author":"Gibb","year":"1980","journal-title":"Steroids"},{"key":"2019041121525531100_B75","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B76","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0039-128X(79)90104-1","article-title":"Metabolism of androstenedione by human ovarian tissues in vitro with particular reference to reductase and aromatase activity","volume":"34","author":"McNatty","year":"1979","journal-title":"Steroids"},{"key":"2019041121525531100_B77","first-page":"2414","article-title":"5\u03b1-reductase activity in women with polycystic ovary syndrome","volume":"84","author":"Jakimiuk","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B78","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1530\/JOE-14-0296","article-title":"Androgen actions in the ovary: balance is key","volume":"222","author":"Prizant","year":"2014","journal-title":"J Endocrinol"},{"key":"2019041121525531100_B79","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1095\/biolreprod.107.064089","article-title":"Androgen actions and the ovary","volume":"78","author":"Walters","year":"2008","journal-title":"Biol Reprod"},{"key":"2019041121525531100_B80","first-page":"4179","article-title":"Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation","volume":"82","author":"Daniels","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B81","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/jcem-35-1-126","article-title":"Mathematical studies of the human menstrual cycle. I. Formation of a mathematical model","volume":"35","author":"Bogumil","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B82","first-page":"2531","article-title":"Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development","volume":"86","author":"Welt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B83","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2010.08.088","article-title":"Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity","volume":"1364","author":"Rosenfield","year":"2010","journal-title":"Brain Res"},{"key":"2019041121525531100_B84","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1095\/biolreprod.105.039800","article-title":"Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator","volume":"72","author":"Foecking","year":"2005","journal-title":"Biol Reprod"},{"key":"2019041121525531100_B85","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1530\/acta.0.0870259","article-title":"Absence of positive feedback effect of oestrogen on LH release in patients with testicular feminization syndrome","volume":"87","author":"Aono","year":"1978","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121525531100_B86","first-page":"527","article-title":"Effect of estrogens and progesterone on gonadotropin and prolactin release in a patient with androgen insensitivity","volume":"58","author":"Nicoletti","year":"1981","journal-title":"Obstet Gynecol"},{"key":"2019041121525531100_B87","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/me.2014-1154","article-title":"Conditional knockout of the androgen receptor in gonadotropes reveals crucial roles for androgen in gonadotropin synthesis and surge in female mice","volume":"28","author":"Wu","year":"2014","journal-title":"Mol Endocrinol"},{"key":"2019041121525531100_B88","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/humrep\/10.1.75","article-title":"Metabolic regulation of androgen production by human thecal cells in vitro","volume":"10","author":"Nahum","year":"1995","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B89","first-page":"302","article-title":"Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries","volume":"81","author":"Willis","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2012.07.011","article-title":"Disordered follicle development","volume":"373","author":"Chang","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121525531100_B91","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1172\/JCI114745","article-title":"Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells","volume":"86","author":"Cara","year":"1990","journal-title":"J Clin Invest"},{"key":"2019041121525531100_B92","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1677\/jme.1.01745","article-title":"The post-endocytotic fate of the gonadotropin receptors is an important determinant of the desensitization of gonadotropin responses","volume":"34","author":"Bhaskaran","year":"2005","journal-title":"J Mol Endocrinol"},{"key":"2019041121525531100_B93","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/me.2014-1132","article-title":"Eukaryotic initiation factor 5A plays an essential role in luteinizing hormone receptor regulation","volume":"28","author":"Menon","year":"2014","journal-title":"Mol Endocrinol"},{"key":"2019041121525531100_B94","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12013-013-9738-x","article-title":"Luteinizing hormone receptors are confined in mesoscale plasma membrane microdomains throughout recovery from receptor desensitization","volume":"68","author":"Wolf-Ringwall","year":"2014","journal-title":"Cell Biochem Biophys"},{"key":"2019041121525531100_B95","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2008-2248","article-title":"Characterization of functionally typical and atypical types of polycystic ovary syndrome","volume":"94","author":"Hirshfeld-Cytron","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B96","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/12.7.1416","article-title":"A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism","volume":"12","author":"Levrant","year":"1997","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B97","doi-asserted-by":"crossref","first-page":"E902","DOI":"10.1152\/ajpendo.00415.2003","article-title":"Exaggerated 17-hydroxyprogesterone response to intravenous infusions of recombinant human LH in women with polycystic ovary syndrome","volume":"286","author":"McCartney","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121525531100_B98","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/edrv.20.3.0370","article-title":"Estrogen receptor null mice: what have we learned and where will they lead us? [erratum appears in Endocr Rev. 1999;20(4):459]","volume":"20","author":"Couse","year":"1999","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B99","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1677\/joe.0.1750269","article-title":"Estrogen actions in the ovary revisited","volume":"175","author":"Britt","year":"2002","journal-title":"J Endocrinol"},{"key":"2019041121525531100_B100","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1096\/fj.06-6681com","article-title":"Estrogen receptor-\u03b1 mediates an intraovarian negative feedback loop on thecal cell steroidogenesis via modulation of Cyp17a1 (cytochrome P450, steroid 17\u03b1-hydroxylase\/17,20 lyase) expression","volume":"21","author":"Taniguchi","year":"2007","journal-title":"FASEB"},{"key":"2019041121525531100_B101","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1007\/s11033-014-3291-6","article-title":"The impact of antiandrogen 2-hydroxyflutamide on the expression of steroidogenic enzymes in cultured porcine ovarian follicles","volume":"41","author":"Duda","year":"2014","journal-title":"Mol Biol Rep"},{"key":"2019041121525531100_B102","first-page":"106","article-title":"The effects of growth factors and phorbol esters on steroid biosynthesis in isolated human theca interna and granulosa-lutein cells in long term culture","volume":"79","author":"McAllister","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/humrep\/17.1.88","article-title":"The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries","volume":"17","author":"Barnes","year":"2002","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B104","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1056\/NEJM200010193431614","article-title":"Effect of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency","volume":"343","author":"Barnes","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/en.2003-0329","article-title":"Insulin augmentation of 17\u03b1-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1\/2 in human ovarian theca cells","volume":"145","author":"Munir","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121525531100_B106","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1095\/biolreprod51.4.766","article-title":"Insulin-like growth factor-I regulation of luteinizing hormone (LH) receptor messenger ribonucleic acid expression and LH-stimulated signal transduction in rat ovarian theca-interstitial cells","volume":"51","author":"Magoffin","year":"1994","journal-title":"Biol Reprod"},{"key":"2019041121525531100_B107","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/jc.2009-0139","article-title":"KLF15 is a transcriptional regulator of the human 17\u03b2-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women","volume":"94","author":"Du","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B108","doi-asserted-by":"crossref","first-page":"E1519","DOI":"10.1073\/pnas.1400574111","article-title":"Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype","volume":"111","author":"McAllister","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121525531100_B109","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.fertnstert.2007.05.003","article-title":"Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-M\u00fcllerian hormone and inhibin-B","volume":"89","author":"Andersen","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.fertnstert.2013.04.016","article-title":"Paracrine regulation of theca androgen production by granulosa cells in the ovary","volume":"100","author":"Hoang","year":"2013","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B111","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/EJE-09-0648","article-title":"A new FSH\u03b2 mutation in a 29-year-old woman with primary amenorrhea and isolated FSH deficiency: functional characterization and ovarian response to human recombinant FSH","volume":"162","author":"Kottler","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2019041121525531100_B112","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/jcem.85.9.6835","article-title":"Bone morphogenetic protein inhibits ovarian androgen production","volume":"85","author":"Dooley","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B113","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/REP-10-0094","article-title":"Theca: the forgotten cell of the ovarian follicle","volume":"140","author":"Young","year":"2010","journal-title":"Reproduction"},{"key":"2019041121525531100_B114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.fertnstert.2013.02.011","article-title":"Ontogeny of the ovary in polycystic ovary syndrome","volume":"100","author":"Dumesic","year":"2013","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B115","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719113485294","article-title":"The role of TGF-\u03b2 in polycystic ovary syndrome","volume":"21","author":"Raja-Khan","year":"2014","journal-title":"Reprod Sci"},{"key":"2019041121525531100_B116","doi-asserted-by":"crossref","first-page":"E1426","DOI":"10.1073\/pnas.1222216110","article-title":"Functional link between bone morphogenetic proteins and insulin-like peptide 3 signaling in modulating ovarian androgen production","volume":"110","author":"Glister","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121525531100_B117","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1096\/fj.11-181099","article-title":"Linkage of regulators of TGF-\u03b2 activity in the fetal ovary to polycystic ovary syndrome","volume":"25","author":"Hatzirodos","year":"2011","journal-title":"FASEB"},{"key":"2019041121525531100_B118","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0035-1554918","article-title":"Nutrient-induced inflammation in polycystic ovary syndrome: role in the development of metabolic aberration and ovarian dysfunction","volume":"33","author":"Gonz\u00e1lez","year":"2015","journal-title":"Semin Reprod Med"},{"key":"2019041121525531100_B119","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1210\/jc.2014-3827","article-title":"MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome","volume":"100","author":"Jiang","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B120","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0015-0282(01)01805-2","article-title":"Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries","volume":"75","author":"Heider","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B121","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1210\/en.2008-1575","article-title":"Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans","volume":"150","author":"Dissen","year":"2009","journal-title":"Endocrinology"},{"key":"2019041121525531100_B122","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cen.12003","article-title":"The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?","volume":"77","author":"Lansdown","year":"2012","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B123","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1210\/en.2014-1368","article-title":"Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome","volume":"155","author":"Wilson","year":"2014","journal-title":"Endocrinology"},{"key":"2019041121525531100_B124","first-page":"71","article-title":"Manipulation of human ovarian function: physiological concepts and clinical consequences","volume":"18","author":"Fauser","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2014-1020","article-title":"Intraovarian control of early folliculogenesis","volume":"36","author":"Hsueh","year":"2015","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B126","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1002\/jcp.25032","article-title":"S100A8, an oocyte-specific chemokine, directs the migration of ovarian somatic cells during mouse primordial follicle assembly","volume":"230","author":"Teng","year":"2015","journal-title":"J Cell Physiol"},{"key":"2019041121525531100_B127","doi-asserted-by":"crossref","first-page":"12664","DOI":"10.1038\/srep12664","article-title":"Bone morphogenetic protein 2 promotes primordial follicle formation in the ovary","volume":"5","author":"Chakraborty","year":"2015","journal-title":"Sci Rep"},{"key":"2019041121525531100_B128","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.18632\/oncotarget.6792","article-title":"LKB1 acts as a critical gatekeeper of ovarian primordial follicle pool","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"2019041121525531100_B129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1126\/science.1086336","article-title":"Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a","volume":"301","author":"Castrillon","year":"2003","journal-title":"Science"},{"key":"2019041121525531100_B130","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1242\/dev.00969","article-title":"The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance","volume":"131","author":"Schmidt","year":"2004","journal-title":"Development"},{"key":"2019041121525531100_B131","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/stem.440","article-title":"BMP signaling in the human fetal ovary is developmentally regulated and promotes primordial germ cell apoptosis","volume":"28","author":"Childs","year":"2010","journal-title":"Stem Cells"},{"key":"2019041121525531100_B132","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/REP-10-0216","article-title":"Changes in expression of bone morphogenetic proteins (BMPs), their receptors and inhibin co-receptor betaglycan during bovine antral follicle development: inhibin can antagonize the suppressive effect of BMPs on thecal androgen production","volume":"140","author":"Glister","year":"2010","journal-title":"Reproduction"},{"key":"2019041121525531100_B133","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"2019041121525531100_B134","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1126\/science.286.5448.2328","article-title":"Postnatal sex reversal of the ovaries in mice lacking estrogen receptors \u03b1 and \u03b2","volume":"286","author":"Couse","year":"1999","journal-title":"Science"},{"key":"2019041121525531100_B135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0303-7207(02)00114-4","article-title":"Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition","volume":"192","author":"Kezele","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121525531100_B136","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J Clin Invest"},{"key":"2019041121525531100_B137","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/humupd\/dmu036","article-title":"The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders","volume":"20","author":"Persani","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2019041121525531100_B138","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","article-title":"Regulation of ovarian follicular development in primates: facts and hypotheses","volume":"17","author":"Gougeon","year":"1996","journal-title":"Endocrin Rev"},{"key":"2019041121525531100_B139","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1210\/endo-108-4-1379","article-title":"Follicle-stimulating hormone induction of luteinizing hormone receptor in cultured rat granulosa cells: an examination of the need for steroids in the induction process","volume":"108","author":"Rani","year":"1981","journal-title":"Endocrinology"},{"key":"2019041121525531100_B140","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1210\/jc.2005-0695","article-title":"Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis","volume":"90","author":"Welt","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/molehr\/4.1.1","article-title":"Aromatase mRNA expression in individual follicles from polycystic ovaries","volume":"4","author":"Jakimiuk","year":"1998","journal-title":"Mol Hum Reprod"},{"key":"2019041121525531100_B142","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"2014 The physiology and clinical utility of anti-Mullerian hormone in women [erratum appears in Hum Reprod Update. 2014;2020(2015):2804]","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2019041121525531100_B143","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humupd\/dmh010","article-title":"The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest","volume":"10","author":"Jonard","year":"2004","journal-title":"Hum Reprod Update"},{"key":"2019041121525531100_B144","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/humrep\/deh873","article-title":"Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B145","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/molehr\/gat065","article-title":"Involvement of androgens in ovarian health and disease","volume":"19","author":"Lebbe","year":"2013","journal-title":"Mol Hum Reprod"},{"key":"2019041121525531100_B146","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1210\/jcem.83.7.4917","article-title":"Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations","volume":"83","author":"Weil","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B147","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B148","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1210\/jc.2006-1697","article-title":"Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-M\u00fcllerian hormone type II receptor in single, isolated, human preantral follicles: relevance to polycystic ovaries","volume":"92","author":"Rice","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B149","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/me.2010-0006","article-title":"Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function","volume":"24","author":"Sen","year":"2010","journal-title":"Mol Endocrinol"},{"key":"2019041121525531100_B150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1095\/biolreprod.112.102012","article-title":"Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral follicles causes female subfertility","volume":"87","author":"Walters","year":"2012","journal-title":"Biol Reprod"},{"key":"2019041121525531100_B151","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0303-7207(01)00469-5","article-title":"Gonadotropic control of ovarian follicular growth and development","volume":"179","author":"Hillier","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121525531100_B152","doi-asserted-by":"crossref","first-page":"E1524","DOI":"10.1210\/jc.2012-1427","article-title":"LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles","volume":"97","author":"Jeppesen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B153","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/humrep\/deu335","article-title":"Direct actions of androgens on the survival, growth and secretion of steroids and anti-M\u00fcllerian hormone by individual macaque follicles during three-dimensional culture","volume":"30","author":"Rodrigues","year":"2015","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B154","first-page":"1132","article-title":"[On the action of intraovarian injection of androgen on follicle and corpus luteum maturation in women]","volume":"25","author":"Hoffman","year":"1965","journal-title":"Geburtshilfe Frauenheilklinic"},{"key":"2019041121525531100_B155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/dmn015","article-title":"Follicle dynamics and anovulation in polycystic ovary syndrome","volume":"14","author":"Franks","year":"2008","journal-title":"Hum Reprod Update"},{"key":"2019041121525531100_B156","first-page":"3984","article-title":"Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation","volume":"83","author":"Willis","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B157","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0950-3552(97)80036-3","article-title":"Role of androgens in follicle maturation and atresia","volume":"11","author":"Hillier","year":"1997","journal-title":"Baillieres Clin Obstet Gynaecol"},{"key":"2019041121525531100_B158","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/REP-10-0483","article-title":"A macrophage and theca cell-enriched stromal cell population influences growth and survival of immature murine follicles in vitro","volume":"141","author":"Tingen","year":"2011","journal-title":"Reproduction"},{"key":"2019041121525531100_B159","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10815-010-9478-4","article-title":"A new hypothesis regarding ovarian follicle development: ovarian rigidity as a regulator of selection and health","volume":"28","author":"Woodruff","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"2019041121525531100_B160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1095\/biolreprod.106.050880","article-title":"Neutralization of endogenous vascular endothelial growth factor depletes primordial follicles in the mouse ovary","volume":"76","author":"Roberts","year":"2007","journal-title":"Biol Reprod"},{"key":"2019041121525531100_B161","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11154-008-9092-2","article-title":"Adrenal changes associated with adrenarche","volume":"10","author":"Nakamura","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"2019041121525531100_B162","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3476(71)80111-7","article-title":"Plasma 17-ketosteroids and 17-\u03b2 hydroxysteroids in girls with premature development of sexual hair","volume":"79","author":"Rosenfield","year":"1971","journal-title":"J Pediatr"},{"key":"2019041121525531100_B163","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jcem-52-6-1129","article-title":"Adrenarche: changing adrenal response to adrenocorticotropin","volume":"52","author":"Rich","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B164","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1043-2760(02)00609-4","article-title":"Dissecting human adrenal androgen production","volume":"13","author":"Rainey","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121525531100_B165","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMoa0810489","article-title":"Inactivating PAPSS2 mutations in a patient with premature pubarche","volume":"360","author":"Noordam","year":"2009","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B166","first-page":"411","article-title":"An adrenal-secreted \u201candrogen\u201d: dehydroisoandrosterone sulfate. Its metabolism and a tentative generalization on the metabolism of other steroid conjugates in man","volume":"21","author":"Baulieu","year":"1965","journal-title":"Rec Prog Horm Res"},{"key":"2019041121525531100_B167","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1210\/en.2009-0410","article-title":"24-dehydrocholesterol reductase\/seladin-1: a key protein differentially involved in adrenocorticotropin effects observed in human and rat adrenal cortex","volume":"150","author":"Battista","year":"2009","journal-title":"Endocrinology"},{"key":"2019041121525531100_B168","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2008-2374","article-title":"Type 5 17\u03b2-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis","volume":"94","author":"Nakamura","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B169","article-title":"The relationship between the production of cortisol and androgen by the human adrenal","volume-title":"The Human Adrenal Cortex","author":"Mills","year":"1962"},{"key":"2019041121525531100_B170","first-page":"583","article-title":"Clinical disorders of adrenal function and puberty: an assessment of the role of the adrenal cortex in normal and abnormal puberty in man and evidence for an ACTH-like pituitary adrenal androgen stimulating hormone","volume-title":"The Endocrine Function of the Human Adrenal Cortex","author":"Grumbach","year":"1978"},{"key":"2019041121525531100_B171","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1210\/endo.141.4.7402","article-title":"Effect of leptin on CYP17 enzymatic activities in human adrenal cells: new insight in the onset of adrenarche","volume":"141","author":"Biason-Lauber","year":"2000","journal-title":"Endocrinology"},{"key":"2019041121525531100_B172","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1210\/jc.2002-020979","article-title":"Relationship between the growth hormone\/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls","volume":"88","author":"Guercio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B173","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1203\/01.PDR.0000179392.59060.93","article-title":"Expression of the IGF system in human adrenal tissues from early infancy to late puberty: implications for the development of adrenarche","volume":"58","author":"Baquedano","year":"2005","journal-title":"Pediatr Res"},{"key":"2019041121525531100_B174","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1210\/jcem-68-5-932","article-title":"Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life","volume":"68","author":"Smith","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B175","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1210\/jcem.86.9.7863","article-title":"The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process","volume":"86","author":"Palmert","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B176","first-page":"3558","article-title":"The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3\u03b2-hydroxysteroid dehydrogenase","volume":"81","author":"Endoh","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B177","first-page":"3892","article-title":"Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells","volume":"81","author":"l'Allemand","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B178","first-page":"175","article-title":"Absent or delayed adrenarche in Pit-1\/POU1F1 deficiency","volume":"64","author":"Taha","year":"2005","journal-title":"Horm Res"},{"key":"2019041121525531100_B179","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/edrv.19.2.0326","article-title":"Intraadrenal interactions in the regulation of adrenocortical steroidogenesis","volume":"19","author":"Ehrhart-Bornstein","year":"1998","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B180","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1210\/en.2014-1942","article-title":"Bone morphogenetic protein-4 (BMP4): a paracrine regulator of human adrenal C19 steroid synthesis","volume":"156","author":"Rege","year":"2015","journal-title":"Endocrinology"},{"key":"2019041121525531100_B181","doi-asserted-by":"crossref","first-page":"10132","DOI":"10.1038\/srep10132","article-title":"Retinoic acid receptor \u03b2 and angiopoietin-like protein 1 are involved in the regulation of human androgen biosynthesis","volume":"5","author":"Udhane","year":"2015","journal-title":"Sci Rep"},{"key":"2019041121525531100_B182","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0065-3101(22)00562-X","article-title":"Role of androgens in growth and development of the fetus, child, and adolescent","volume":"19","author":"Rosenfield","year":"1972","journal-title":"Adv Pediatr"},{"key":"2019041121525531100_B183","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-961807","article-title":"Sexual hormones in human skin","volume":"39","author":"Zouboulis","year":"2007","journal-title":"Horm Metab Res"},{"key":"2019041121525531100_B184","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/joe.1.05762","article-title":"Androgen generation in adipose tissue in women with simple obesity\u2013a site-specific role for 17\u03b2-hydroxysteroid dehydrogenase type 5","volume":"183","author":"Quinkler","year":"2004","journal-title":"J Endocrinol"},{"key":"2019041121525531100_B185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0026-0495(86)90206-4","article-title":"Androgen and estrogen metabolism: relationship to obesity","volume":"35","author":"Longcope","year":"1986","journal-title":"Metabolism"},{"key":"2019041121525531100_B186","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-2002-38265","article-title":"Adipose tissue intracrinology: potential importance of local androgen\/estrogen metabolism in the regulation of adiposity","volume":"34","author":"B\u00e9langer","year":"2002","journal-title":"Horm Metab Res"},{"key":"2019041121525531100_B187","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B188","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.ijo.0801254","article-title":"Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue","volume":"24","author":"McTernan","year":"2000","journal-title":"Int J Obes Rel Metab Disord"},{"key":"2019041121525531100_B189","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1940-6207.CAPR-10-0381","article-title":"Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland","volume":"4","author":"Subbaramaiah","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"2019041121525531100_B190","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1210\/jc.2003-030240","article-title":"Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5\u03b1-reduction but not the elevated adrenal steroid production rates","volume":"88","author":"Tsilchorozidou","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B191","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jcem-56-2-320","article-title":"Dihydrotestosterone stimulates 5\u03b1-reductase activity in public skin fibroblasts","volume":"53","author":"Mowszowicz","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B192","first-page":"25","article-title":"The role of proteins in the distribution of plasma androgens and estradiol","volume-title":"Androgenization in Women","author":"Rosenfield","year":"1983"},{"key":"2019041121525531100_B193","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mce.2009.09.020","article-title":"Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome","volume":"316","author":"Pugeat","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121525531100_B194","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db11-0727","article-title":"Potential role of tumor necrosis factor-\u03b1 in downregulating sex hormone-binding globulin","volume":"61","author":"Sim\u00f3","year":"2012","journal-title":"Diabetes"},{"key":"2019041121525531100_B196","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1172\/JCI0214060","article-title":"Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction","volume":"109","author":"Hogeveen","year":"2002","journal-title":"J Clin Invest"},{"key":"2019041121525531100_B197","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1210\/jc.2008-2771","article-title":"Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population","volume":"94","author":"Mortensen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B198","first-page":"1686","article-title":"Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism","volume":"79","author":"Rosenfield","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B199","first-page":"4103","article-title":"Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing","volume":"81","author":"Iba\u00f1ez","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/jcem-51-2-345","article-title":"Pubertal presentation of congenital \u03945\u20133\u03b2-hydroxysteroid dehydrogenase deficiency","volume":"51","author":"Rosenfield","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B201","first-page":"1328","article-title":"Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women","volume":"79","author":"Barnes","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B202","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJM199410133311502","article-title":"Identification of virilizing adrenal tumors in hirsute women","volume":"331","author":"Derksen","year":"1994","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B203","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1210\/jc.2002-020922","article-title":"The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women","volume":"88","author":"Kaltsas","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B204","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B206","first-page":"2275","article-title":"Hyperandrogenism, hirsutism, and the polycystic ovary syndrome","volume-title":"Endocrinology","author":"Rosenfield","year":"2015","edition":"7th ed"},{"key":"2019041121525531100_B207","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome","volume":"47","author":"Gilling-Smith","year":"1997","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B208","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1210\/jc.2007-0870","article-title":"17-Hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome","volume":"92","author":"Pasquali","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B209","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/jc.2014-2956","article-title":"Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome","volume":"100","author":"Maas","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B210","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B211","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2013-2385","article-title":"Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis","volume":"98","author":"Domecq","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B212","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2013a common finding in normal women","volume":"331","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"2019041121525531100_B213","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1479-828X.1994.tb01041.x","article-title":"The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women","volume":"34","author":"Farquhar","year":"1994","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2019041121525531100_B214","first-page":"995","article-title":"Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing","volume":"85","author":"Chang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B215","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/jc.2010-0202","article-title":"The polycystic ovary post-Rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance","volume":"95","author":"Johnstone","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B216","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","article-title":"Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)","volume":"94","author":"Hart","year":"2010","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B217","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/humrep\/der223","article-title":"Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone","volume":"26","author":"Villarroel","year":"2011","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B218","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype","volume":"90","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B219","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1210\/jc.2006-1085","article-title":"Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome","volume":"91","author":"Murphy","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B220","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/jc.2013-3781","article-title":"Increased androgen, anti-M\u00fcllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?","volume":"99","author":"Sjaarda","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B221","doi-asserted-by":"crossref","first-page":"E845","DOI":"10.1210\/jc.2015-1298","article-title":"The relationship between variation in size of the primordial follicle pool and age at natural menopause","volume":"100","author":"Depmann","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B222","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.diii.2015.02.004","article-title":"Adrenal gland volume assessed by magnetic resonance imaging in women with polycystic ovary syndrome","volume":"97","author":"Unlu","year":"2016","journal-title":"Diagn Interv Imaging"},{"key":"2019041121525531100_B223","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0026-0495(85)90023-X","article-title":"A genetic component to the variation of dehydroepiandrosterone sulfate","volume":"34","author":"Rotter","year":"1985","journal-title":"Metabolism"},{"key":"2019041121525531100_B224","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0026-0495(93)90126-9","article-title":"The Cincinnati Myocardial Infarction and Hormone Family Study: family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families","volume":"42","author":"Rice","year":"1993","journal-title":"Metabolism"},{"key":"2019041121525531100_B225","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1210\/jc.2013-1976","article-title":"Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype","volume":"98","author":"Louwers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B226","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1210\/jc.2006-2274","article-title":"Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women","volume":"92","author":"Jain","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B227","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ijo.2012.9","article-title":"Adiposity and sex hormones across the menstrual cycle: the BioCycle Study","volume":"37","author":"Yeung","year":"2013","journal-title":"Int J Obes"},{"key":"2019041121525531100_B228","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/cen.12441","article-title":"Luteal phase dynamics of follicle-stimulating and luteinizing hormones in obese and normal weight women","volume":"81","author":"Roth","year":"2014","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B229","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1210\/jc.2015-1946","article-title":"Estradiol priming improves gonadotrope sensitivity and pro-inflammatory cytokines in obese women","volume":"100","author":"Al-Safi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B230","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2559.1991.tb00235.x","article-title":"Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?","volume":"19","author":"Pache","year":"1991","journal-title":"Histopathology"},{"key":"2019041121525531100_B231","doi-asserted-by":"crossref","first-page":"S095","DOI":"10.1067\/mjd.2001.117430","article-title":"Polycystic ovary syndrome and insulin-resistant hyperinsulinemia","volume":"45","author":"Rosenfield","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"2019041121525531100_B232","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B233","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1067\/mpd.2001.109603","article-title":"Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome","volume":"138","author":"Lewy","year":"2001","journal-title":"J Pediatr"},{"key":"2019041121525531100_B234","first-page":"3115","article-title":"Phosphatidyl-inositol-3 kinase-independent insulin action pathway(s) in the human ovary","volume":"86","author":"Poretsky","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B235","first-page":"1318","article-title":"Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries","volume":"86","author":"Jakimiuk","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B236","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tem.2014.12.004","article-title":"Functional genomics of PCOS: from GWAS to molecular mechanisms","volume":"26","author":"McAllister","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121525531100_B237","first-page":"1285","article-title":"Diagnosis of polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism","volume":"13","author":"Rosenfield","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019041121525531100_B238","first-page":"2317","article-title":"Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis","volume":"83","author":"Azziz","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B239","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J Ster Biochem Mol Biol"},{"key":"2019041121525531100_B240","first-page":"450","article-title":"Ovarian steroidogenic responses to the gonadotropin-releasing hormone agonist nafarelin in hirsute women thought to have 3\u03b2-hydroxysteroid dehydrogenase deficiency","volume":"76","author":"Barnes","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B241","first-page":"2611","article-title":"Newly proposed hormonal criteria via genotypic proof for type II 3\u03b2-hydroxysteroid dehydrogenase deficiency","volume":"87","author":"Lutfallah","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B242","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jc.2003-030934","article-title":"The hormonal phenotype of nonclassic 3 \u03b2-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency","volume":"89","author":"Carbunaru","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B243","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0015-0282(16)58500-8","article-title":"Evidence for heterogeneous etiologies of adrenal dysfunction in polycystic ovary syndrome","volume":"66","author":"Gonzalez","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B244","first-page":"878","article-title":"Evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved","volume":"81","author":"Rosenfield","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B245","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B246","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/jc.2008-0714","article-title":"Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial","volume":"93","author":"Mai","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B247","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.steroids.2011.12.017","article-title":"Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells","volume":"77","author":"Bellanger","year":"2012","journal-title":"Steroids"},{"key":"2019041121525531100_B248","first-page":"603","article-title":"The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome","volume":"80","author":"Ditkoff","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B249","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1210\/jc.2010-0692","article-title":"Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3\u03b2HSD2","volume":"96","author":"Topor","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B250","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jc.2009-0837","article-title":"Increased 5 \u03b1-reductase activity and adrenocortical drive in women with polycystic ovary syndrome","volume":"94","author":"Vassiliadi","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B251","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1210\/jc.2005-2222","article-title":"Genetic variation in 11\u03b2-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B252","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1210\/jc.2013-1385","article-title":"Ovarian 11\u03b2-hydroxysteroid dehydrogenase (11\u03b2HSD) activity is suppressed in women with anovulatory polycystic ovary syndrome (PCOS): apparent role for ovarian androgens","volume":"98","author":"Michael","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B253","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1447-0756.2009.01103.x","article-title":"Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome","volume":"36","author":"Zhu","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"2019041121525531100_B254","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated theca cells from polycystic ovaries","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B255","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1095\/biolreprod55.2.416","article-title":"Developmental and hormonal regulation of rat theca-cell differentiation factor secretion in ovarian follicles","volume":"55","author":"Magarelli","year":"1996","journal-title":"Biol Reprod"},{"key":"2019041121525531100_B256","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1038\/ncomms7934","article-title":"Lineage specification of ovarian theca cells requires multicellular interactions via oocyte and granulosa cells","volume":"6","author":"Liu","year":"2015","journal-title":"Nat Commun"},{"key":"2019041121525531100_B257","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006254-198202000-00001","article-title":"Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called \u201chyperthecosis.\u201d","volume":"37","author":"Hughesdon","year":"1982","journal-title":"Obstet Gynecol Surv"},{"key":"2019041121525531100_B258","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"2019041121525531100_B259","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1210\/jc.2006-1422","article-title":"Prolonged survival in culture of preantral follicles from polycystic ovaries","volume":"92","author":"Webber","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B260","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s10815-014-0319-8","article-title":"Reduced and delayed expression of GDF9 and BMP15 in ovarian tissues from women with polycystic ovary syndrome","volume":"31","author":"Wei","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"2019041121525531100_B261","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/jc.2006-1582","article-title":"Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries","volume":"92","author":"Pellatt","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B262","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/humrep\/dev131","article-title":"The phenotypic diversity in per-follicle anti-Mullerian hormone production in polycystic ovary syndrome","volume":"30","author":"Alebi\u0107","year":"2015","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B263","first-page":"1355","article-title":"Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid","volume":"79","author":"Mason","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B264","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1210\/jc.2002-021280","article-title":"Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome","volume":"88","author":"Coffler","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B265","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1095\/biolreprod.102.011494","article-title":"Developmental regulation of follicle-stimulating hormone receptor messenger RNA expression in the baboon fetal ovary","volume":"68","author":"Zachos","year":"2003","journal-title":"Biol Reprod"},{"key":"2019041121525531100_B266","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJMoa071999","article-title":"Luteinizing hormone \u03b2 mutation and hypogonadism in men and women","volume":"357","author":"Lofrano-Porto","year":"2007","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B267","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/oxfordjournals.humrep.a138123","article-title":"The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome","volume":"8","author":"Scheele","year":"1993","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B268","first-page":"1488","article-title":"Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF- binding proteins-1\u20136 and the localization of their gene products in normal and polycystic ovary syndrome ovaries","volume":"78","author":"el-Roeiy","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B269","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/humupd\/dml058","article-title":"Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome","volume":"13","author":"Hendriks","year":"2007","journal-title":"Hum Reprod Update"},{"key":"2019041121525531100_B270","first-page":"600","article-title":"[The differential expression profile of polycystic ovary syndrome associated genes]","volume":"36","author":"Hu","year":"2004","journal-title":"Beijing Da Xue Xue Bao"},{"key":"2019041121525531100_B271","doi-asserted-by":"crossref","first-page":"E2016","DOI":"10.1210\/jc.2011-3441","article-title":"Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis","volume":"97","author":"Kaur","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B272","doi-asserted-by":"crossref","first-page":"14994","DOI":"10.1038\/srep14994","article-title":"Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK\/ERK signaling","volume":"5","author":"Lan","year":"2015","journal-title":"Sci Rep"},{"key":"2019041121525531100_B273","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jc.2006-2123","article-title":"Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis","volume":"92","author":"Wood","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B274","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(10)60751-9","article-title":"The association between pregnancy weight gain and birthweight: a within-family comparison","volume":"376","author":"Ludwig","year":"2010","journal-title":"Lancet"},{"key":"2019041121525531100_B275","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jgyn.2008.12.001","article-title":"[Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory]","volume":"38","author":"Kdous","year":"2009","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"2019041121525531100_B276","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"2019041121525531100_B277","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"2019041121525531100_B278","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B279","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B280","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1210\/jc.2005-1707","article-title":"Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome","volume":"91","author":"Leibel","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B281","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpeds.2011.04.027","article-title":"Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome","volume":"159","author":"Nandalike","year":"2011","journal-title":"J Pediatr"},{"key":"2019041121525531100_B282","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/jc.2008-1198","article-title":"Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome","volume":"93","author":"Rossi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B283","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B284","first-page":"4047","article-title":"Clinical review 135: the importance of \u03b2-cell failure in the development and progression of type 2 diabetes","volume":"86","author":"Kahn","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B285","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B286","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1993.tb02376.x","article-title":"The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries","volume":"39","author":"Robinson","year":"1993","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B287","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2015-2778","article-title":"Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome","volume":"100","author":"Legro","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B288","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11695-015-1729-0","article-title":"Roux-en-Y gastric bypass surgery in patients with polycystic ovary syndrome and metabolic syndrome","volume":"26","author":"Turkmen","year":"2016","journal-title":"Obes Surg"},{"key":"2019041121525531100_B289","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041121525531100_B290","first-page":"942","article-title":"\u03b2-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B291","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"2019041121525531100_B292","first-page":"2027","article-title":"Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives","volume":"86","author":"Colilla","year":"2001","journal-title":"J Clin Endocrinol Metaab"},{"key":"2019041121525531100_B293","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome","volume":"41","author":"Dunaif","year":"1992","journal-title":"Diabetes"},{"key":"2019041121525531100_B294","doi-asserted-by":"crossref","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","article-title":"Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling","volume":"288","author":"Corbould","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121525531100_B295","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1210\/jc.2014-2786","article-title":"Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome","volume":"100","author":"Tosi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B296","first-page":"3110","article-title":"Selective insulin resistance in the polycystic ovary syndrome","volume":"84","author":"Book","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B297","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B298","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1210\/jcem.80.12.8530637","article-title":"Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor","volume":"80","author":"Willis","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B299","doi-asserted-by":"crossref","first-page":"e0119995","DOI":"10.1371\/journal.pone.0119995","article-title":"Insulin receptor signaling in the GnRH neuron plays a role in the abnormal GnRH pulsatility of obese female mice","volume":"10","author":"DiVall","year":"2015","journal-title":"PLoS One"},{"key":"2019041121525531100_B300","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0039-128X(96)00223-1","article-title":"Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells","volume":"62","author":"Kristiansen","year":"1997","journal-title":"Steroids"},{"key":"2019041121525531100_B301","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jc.2011-1896","article-title":"Insulin resistance is a sufficient basis for hyperandrogenism in lipodystrophic women with polycystic ovarian syndrome","volume":"97","author":"Lungu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B302","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2265.2007.02987.x","article-title":"Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly","volume":"67","author":"Kaltsas","year":"2007","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B303","first-page":"1533","article-title":"Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resisitance","volume":"76","author":"Flier","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B304","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2265.2000.00884.x","article-title":"The prevalence of polycystic ovaries in women with type 2 diabetes mellitus","volume":"52","author":"Conn","year":"2000","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B305","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","article-title":"Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes","volume":"24","author":"Peppard","year":"2001","journal-title":"Diabetes Care"},{"key":"2019041121525531100_B306","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1210\/jc.2006-2641","article-title":"Clinical review: hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus","volume":"92","author":"Codner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B307","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17a activity and serum free testosterone after reduction of insulin secretion in women with polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B308","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.soard.2005.02.008","article-title":"Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass","volume":"1","author":"Eid","year":"2005","journal-title":"Surg Obes Relat Dis"},{"key":"2019041121525531100_B309","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1210\/jc.2007-1188","article-title":"The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome","volume":"92","author":"Moran","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B310","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(03)13493-9","article-title":"Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome","volume":"361","author":"Harborne","year":"2003","journal-title":"Lancet"},{"key":"2019041121525531100_B311","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/jc.2007-2429","article-title":"Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Cosma","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B312","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"issue":"5","key":"2019041121525531100_B313","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121525531100_B314","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/09513590701672405","article-title":"Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction","volume":"23","author":"Papaleo","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"2019041121525531100_B315","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejogrb.2015.09.024","article-title":"Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS","volume":"195","author":"Facchinetti","year":"2015","journal-title":"Europ J Obstet Gynecol Reprod Biol"},{"key":"2019041121525531100_B316","doi-asserted-by":"crossref","first-page":"E902","DOI":"10.1210\/jc.2013-1041","article-title":"Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity","volume":"98","author":"Ib\u00e1\u00f1ez","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B317","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrendo.2014.58","article-title":"Hyperinsulinaemic androgen excess in adolescent girls","volume":"10","author":"Ib\u00e1\u00f1ez","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"2019041121525531100_B318","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2019041121525531100_B319","first-page":"1237","article-title":"Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism","volume":"81","author":"Ibanez","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B320","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B321","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1210\/jc.2013-4021","article-title":"Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study","volume":"99","author":"Pau","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B322","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"2019041121525531100_B323","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2013mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"2019041121525531100_B324","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"2019041121525531100_B325","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/dc15-0488","article-title":"The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies","volume":"39","author":"Buse","year":"2015","journal-title":"Diabetes Care"},{"key":"2019041121525531100_B326","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jc.2007-1736","article-title":"Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B327","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1477-7827-12-98","article-title":"Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects","volume":"12","author":"Kurzthaler","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"2019041121525531100_B328","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1210\/en.2014-1765","article-title":"Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model","volume":"156","author":"Di Pietro","year":"2015","journal-title":"Endocrinology"},{"key":"2019041121525531100_B329","doi-asserted-by":"crossref","first-page":"E1491","DOI":"10.1210\/jc.2013-1865","article-title":"Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome","volume":"98","author":"Rice","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B330","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/cc11664","article-title":"Metformin overdose: time to move on","volume":"16","author":"Orban","year":"2012","journal-title":"Crit Care"},{"key":"2019041121525531100_B331","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03401383","article-title":"A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome","volume":"14","author":"Jensterle","year":"2015","journal-title":"Hormones"},{"key":"2019041121525531100_B332","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1530\/EJE-13-0797","article-title":"Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin","volume":"170","author":"Jensterle Sever","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2019041121525531100_B333","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1210\/en.2014-1978","article-title":"GLP-1 increases preovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats","volume":"156","author":"Outeiri\u00f1o-Iglesias","year":"2015","journal-title":"Endocrinology"},{"key":"2019041121525531100_B334","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1155\/EDR.2003.169","article-title":"Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes","volume":"4","author":"Kahn","year":"2003","journal-title":"Exp Diabesity Res"},{"key":"2019041121525531100_B335","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","article-title":"What we talk about when we talk about fat","volume":"156","author":"Rosen","year":"2014","journal-title":"Cell"},{"key":"2019041121525531100_B336","first-page":"577","article-title":"Cellular mechanisms of insulin resistance in polycystic ovarian syndrome","volume":"75","author":"Ciaraldi","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B337","first-page":"1421","article-title":"Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity","volume":"82","author":"Ciaraldi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B338","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/0026-0495(94)90013-2","article-title":"Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome","volume":"43","author":"Marsden","year":"1994","journal-title":"Metabolism"},{"key":"2019041121525531100_B339","first-page":"E197","article-title":"Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes","volume":"264","author":"Rosenbaum","year":"1993","journal-title":"Am J Physiol"},{"key":"2019041121525531100_B340","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/db12-0963","article-title":"miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance","volume":"62","author":"Chen","year":"2013","journal-title":"Diabetes"},{"key":"2019041121525531100_B341","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.metabol.2006.12.021","article-title":"The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome","volume":"56","author":"Corbould","year":"2007","journal-title":"Metabolism"},{"key":"2019041121525531100_B342","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1677\/joe.1.07070","article-title":"Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women","volume":"192","author":"Corbould","year":"2007","journal-title":"J Endocrinol"},{"key":"2019041121525531100_B343","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/dmrr.872","article-title":"Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?","volume":"24","author":"Corbould","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"2019041121525531100_B344","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1210\/en.2011-2111","article-title":"Androgen effects on adipose tissue architecture and function in nonhuman primates","volume":"153","author":"Varlamov","year":"2012","journal-title":"Endocrinology"},{"key":"2019041121525531100_B345","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/JME-13-0201","article-title":"Opposite effects of 17-\u03b2 estradiol and testosterone on mitochondrial biogenesis and adiponectin synthesis in white adipocytes","volume":"52","author":"Capllonch-Amer","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"2019041121525531100_B346","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1210\/jc.2012-2697","article-title":"PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity","volume":"98","author":"Huang","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B347","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1007\/s13277-013-1595-0","article-title":"Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"key":"2019041121525531100_B348","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.steroids.2013.05.001","article-title":"Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation","volume":"78","author":"Chazenbalk","year":"2013","journal-title":"Steroids"},{"key":"2019041121525531100_B349","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1210\/en.2014-1050","article-title":"Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys","volume":"155","author":"Keller","year":"2014","journal-title":"Endocrinology"},{"key":"2019041121525531100_B350","first-page":"265","article-title":"Induction of insulin resistance by androgens and estrogens","volume":"79","author":"Polderman","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B351","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1210\/en.2013-1428","article-title":"Ovarian cycle-specific regulation of adipose tissue lipid storage by testosterone in female nonhuman primates","volume":"154","author":"Varlamov","year":"2013","journal-title":"Endocrinology"},{"key":"2019041121525531100_B352","doi-asserted-by":"crossref","first-page":"E1397","DOI":"10.1210\/jc.2014-1395","article-title":"5\u03b1-reductase type 1 modulates insulin sensitivity in men","volume":"99","author":"Upreti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B353","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2337\/db14-0249","article-title":"5\u03b1-Reductase type 1 deficiency or inhibition predisposes to insulin resistance, hepatic steatosis, and liver fibrosis in rodents","volume":"64","author":"Livingstone","year":"2015","journal-title":"Diabetes"},{"key":"2019041121525531100_B354","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbadis.2013.05.029","article-title":"Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2019041121525531100_B355","doi-asserted-by":"crossref","first-page":"E2482","DOI":"10.1073\/pnas.1323681111","article-title":"11\u03b2-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess","volume":"111","author":"Morgan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121525531100_B356","doi-asserted-by":"crossref","first-page":"E241","DOI":"10.1152\/ajpendo.00475.2003","article-title":"Impaired \u03b2-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome","volume":"287","author":"Ehrmann","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121525531100_B357","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11\u03b2-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol Rev"},{"key":"2019041121525531100_B358","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-16-0121","article-title":"Adipocyte glucocorticoid receptor has a minor contribution in adipose tissue growth","volume":"230","author":"Desarzens","year":"2016","journal-title":"J Endocrinol"},{"key":"2019041121525531100_B359","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121525531100_B360","doi-asserted-by":"crossref","first-page":"E1088","DOI":"10.1210\/jc.2013-1295","article-title":"Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome","volume":"98","author":"Ezeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B361","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"Kirchengast","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B362","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2007-2117","article-title":"Global adiposity rather than abnormal regional fat distribution characterises women with polycystic ovary syndrome","volume":"93","author":"Barber","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B363","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1210\/jc.2010-1290","article-title":"Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manner\u00e5s-Holm","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B364","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2012-3698","article-title":"Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS)","volume":"98","author":"Borruel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B365","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biochi.2004.11.012","article-title":"Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome","volume":"87","author":"Arner","year":"2005","journal-title":"Biochimie"},{"key":"2019041121525531100_B366","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diabetes.51.2.484","article-title":"A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance","volume":"51","author":"Ek","year":"2002","journal-title":"Diabetes"},{"key":"2019041121525531100_B367","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1210\/jc.2002-021573","article-title":"Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome","volume":"88","author":"Faulds","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B368","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-003-1324-0","article-title":"Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots","volume":"47","author":"Dicker","year":"2004","journal-title":"Diabetologia"},{"key":"2019041121525531100_B369","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"key":"2019041121525531100_B370","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1210\/jc.2015-2712","article-title":"Phenotypic characterization of insulin-resistant and insulin-sensitive obesity","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B371","article-title":"Hyperandrogenemia induces adipose tissue dysfunction in adolescent female rhesus macaques consuming a western-style diet","volume":"37","author":"Varlamov","year":"2016","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B372","doi-asserted-by":"crossref","first-page":"E2244","DOI":"10.1210\/jc.2014-2046","article-title":"The altered mononuclear cell-derived cytokine response to glucose ingestion is not regulated by excess adiposity in polycystic ovary syndrome","volume":"99","author":"Gonz\u00e1lez","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B373","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-0035-1556568","article-title":"The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome","volume":"33","author":"Shorakae","year":"2015","journal-title":"Semin Reprod Med"},{"key":"2019041121525531100_B374","doi-asserted-by":"crossref","first-page":"E848","DOI":"10.1210\/jc.2013-4109","article-title":"Hyperandrogenism induces a proinflammatory TNF\u03b1 response to glucose ingestion in a receptor-dependent fashion","volume":"99","author":"Gonz\u00e1lez","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B375","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/jc.2005-1084","article-title":"Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome","volume":"91","author":"Tasali","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B376","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/jc.2010-1187","article-title":"Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome","volume":"96","author":"Tasali","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B377","first-page":"517","article-title":"Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B378","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-157-8-201210160-00005","article-title":"Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study","volume":"157","author":"Broussard","year":"2012","journal-title":"Ann Intern Med"},{"key":"2019041121525531100_B379","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.steroids.2011.12.001","article-title":"Metabolic dysfunction in PCOS: relationship to obstructive sleep apnea","volume":"77","author":"Ehrmann","year":"2012","journal-title":"Steroids"},{"key":"2019041121525531100_B380","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/01.CIR.98.11.1071","article-title":"Altered cardiovascular variability in obstructive sleep apnea","volume":"98","author":"Narkiewicz","year":"1998","journal-title":"Circulation"},{"key":"2019041121525531100_B381","doi-asserted-by":"crossref","first-page":"E576","DOI":"10.1152\/ajpendo.00725.2007","article-title":"Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?","volume":"294","author":"Sverrisd\u00f3ttir","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121525531100_B382","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cen.12803","article-title":"Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance","volume":"83","author":"Lambert","year":"2015","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B383","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2265.1994.tb02578.x","article-title":"The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women","volume":"41","author":"Holte","year":"1994","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B384","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B385","first-page":"3728","article-title":"Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity","volume":"82","author":"Arroyo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B386","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.fertnstert.2008.08.025","article-title":"Partial recovery of luteal function after bariatric surgery in obese women","volume":"92","author":"Rochester","year":"2009","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B387","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2005-2099","article-title":"Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions","volume":"91","author":"Pag\u00e1n","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B388","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1210\/jc.2006-2716","article-title":"Pharmacokinetic factors contribute to the inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome","volume":"92","author":"Srouji","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B389","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1210\/jc.2008-2070","article-title":"Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women","volume":"94","author":"Wide","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B390","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1210\/jc.2007-1342","article-title":"Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men","volume":"92","author":"Wide","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B391","first-page":"1815","article-title":"Ablation of GalNAc-4-sulfotransferase-1 enhances reproduction by altering the carbohydrate structures of luteinizing hormone in mice","volume":"118","author":"Mi","year":"2008","journal-title":"J Clin Invest"},{"key":"2019041121525531100_B392","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1210\/jc.2003-030167","article-title":"Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids","volume":"88","author":"Eagleson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B393","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1210\/jc.2007-2656","article-title":"Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women","volume":"93","author":"Lawson","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B394","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/jc.2004-1040","article-title":"Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment","volume":"90","author":"Mehta","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B395","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0026-0495(03)00186-0","article-title":"Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone","volume":"52","author":"Zumoff","year":"2003","journal-title":"Metabolism"},{"key":"2019041121525531100_B396","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1056\/NEJM197905033001808","article-title":"Reduction of the potency of luteinizing hormone by estrogen","volume":"300","author":"Lucky","year":"1979","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B397","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/jc.2002-020982","article-title":"Hormonal profile of women with self-reported symptoms of oligomenorrhea and\/or hirsutism: Northern Finland birth cohort 1966 study","volume":"88","author":"Taponen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B398","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-2003-41358","article-title":"Sex difference in the effect of obesity on 24-hour mean serum gonadotropin levels","volume":"35","author":"Strain","year":"2003","journal-title":"Horm Metab Res"},{"key":"2019041121525531100_B399","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Austral"},{"key":"2019041121525531100_B400","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.soard.2011.09.022","article-title":"Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis","volume":"8","author":"Jamal","year":"2012","journal-title":"Surg Obes Relat Dis"},{"key":"2019041121525531100_B401","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O'Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B402","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1210\/jcem.87.5.8484","article-title":"Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone","volume":"87","author":"McCartney","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B403","first-page":"582","article-title":"Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"83","author":"Pastor","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B404","first-page":"4047","article-title":"Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"85","author":"Eagleson","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B405","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1210\/jc.2009-0402","article-title":"Acute effects of testosterone infusion on the serum luteinizing hormone profile in eumenorrheic and polycystic ovary syndrome adolescents","volume":"94","author":"Ropelato","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B406","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat Commun"},{"key":"2019041121525531100_B407","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/j.fertnstert.2010.04.019","article-title":"Potential diagnostic utility of intermittent administration of short-acting GnRH agonist administration in gonadotropin deficiency","volume":"94","author":"Zimmer","year":"2010","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B408","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B409","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsbmb.2015.11.005","article-title":"Development of a novel cell based androgen screening model","volume":"156","author":"Campana","year":"2016","journal-title":"J Ster Biochem Mol Biol"},{"key":"2019041121525531100_B410","article-title":"The backdoor androgen biosynthesis pathway exists in the human ovary and seems altered in PCOS","volume":"37","author":"Marti","year":"2016","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B411","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/jcem-32-5-625","article-title":"Androgens and androgen responsiveness in the feminizing testis syndrome. Comparison of complete and \u201cincomplete\u201d forms","volume":"32","author":"Rosenfield","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B412","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1210\/en.2010-0444","article-title":"Stimulatory effect of insulin on 5\u03b1-reductase type 1 (SRD5A1) expression through an Akt-dependent pathway in ovarian granulosa cells","volume":"151","author":"Kayampilly","year":"2010","journal-title":"Endocrinology"},{"key":"2019041121525531100_B413","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2006-0227","article-title":"Variants in the 5\u03b1-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women","volume":"91","author":"Goodarzi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B414","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/cen.12809","article-title":"Women with polycystic ovary syndrome have elevated serum concentrations of and altered GABA(A) receptor sensitivity to allopregnanolone","volume":"83","author":"Hedstrom","year":"2015","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B415","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1073\/pnas.1418216112","article-title":"Alternative splicing of the androgen receptor in polycystic ovary syndrome","volume":"112","author":"Wang","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121525531100_B416","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/1008-682X.161600","article-title":"Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?","volume":"18","author":"Walters","year":"2016","journal-title":"Asian J Androl"},{"key":"2019041121525531100_B417","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B418","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.gene.2013.04.040","article-title":"Association of the CAG repeat polymorphisms in androgen receptor gene with polycystic ovary syndrome: a systemic review and meta-analysis","volume":"524","author":"Zhang","year":"2013","journal-title":"Gene"},{"key":"2019041121525531100_B419","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B420","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121525531100_B421","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1210\/jc.2008-0369","article-title":"Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries","volume":"93","author":"Franks","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B422","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1210\/jcem.84.1.5382","article-title":"Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families","volume":"84","author":"Govind","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B423","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B424","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1073\/pnas.0602025103","article-title":"Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome","volume":"103","author":"Sam","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121525531100_B425","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1210\/jc.2004-2217","article-title":"Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome","volume":"90","author":"Sam","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B426","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2009-1333","article-title":"High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity","volume":"94","author":"Coviello","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B427","doi-asserted-by":"crossref","first-page":"E2006","DOI":"10.1210\/jc.2013-2495","article-title":"Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome","volume":"98","author":"Louwers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B428","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1479-828X.2001.tb01210.x","article-title":"The impact of ethnicity on the presentation of polycystic ovarian syndrome","volume":"41","author":"Williamson","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2019041121525531100_B429","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2265.2010.03873.x","article-title":"Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark","volume":"73","author":"Glintborg","year":"2010","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B430","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0889-8529(18)30409-2","article-title":"Familial polycystic ovarian disease","volume":"17","author":"Givens","year":"1988","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2019041121525531100_B431","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Identifying children at risk of polycystic ovary syndrome","volume":"92","author":"Rosenfield","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B432","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1210\/jc.2008-2836","article-title":"Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Sir-Petermann","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B433","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1210\/jc.2009-0427","article-title":"Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome","volume":"94","author":"Maliqueo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B434","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1210\/jc.2005-2693","article-title":"Increased anti-mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome","volume":"91","author":"Sir-Petermann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B435","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.fertnstert.2011.11.021","article-title":"Androgens and antimullerian hormone in mothers with polycystic ovary syndrome and their newborns","volume":"97","author":"Vanky","year":"2012","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B436","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/jc.2007-1958","article-title":"Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study","volume":"93","author":"Kent","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B437","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2265.1993.tb02150.x","article-title":"Evidence for a single gene effect causing polycystic ovaries and male pattern baldness","volume":"38","author":"Carey","year":"1993","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B438","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1210\/jc.2007-1716","article-title":"The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome","volume":"93","author":"Wang","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B439","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1210\/jc.2012-1836","article-title":"Polycystic ovary-like abnormalities (PCO-L) in women with functional hypothalamic amenorrhea","volume":"97","author":"Robin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B440","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ymgme.2011.08.035","article-title":"Shared genetic variance between the features of the metabolic syndrome: heritability studies","volume":"104","author":"Povel","year":"2011","journal-title":"Mol Genet Metab"},{"key":"2019041121525531100_B441","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.trsl.2014.05.010","article-title":"The genetics of human obesity","volume":"164","author":"Waalen","year":"2014","journal-title":"Transl Res"},{"key":"2019041121525531100_B442","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome","volume":"88","author":"Yildiz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B443","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1210\/jc.2013-4338","article-title":"Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome","volume":"99","author":"Kobaly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B444","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121525531100_B445","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2019041121525531100_B446","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ncpendmet0400","article-title":"The genetics of the polycystic ovary syndrome","volume":"3","author":"Urbanek","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041121525531100_B447","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/bmme.1997.2632","article-title":"Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency","volume":"62","author":"Witchel","year":"1997","journal-title":"Biochem Mol Med"},{"key":"2019041121525531100_B448","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2009-2703","article-title":"Family-based analysis of candidate genes for polycystic ovary syndrome","volume":"95","author":"Ewens","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B449","doi-asserted-by":"crossref","first-page":"E1750","DOI":"10.1210\/jc.2011-2153","article-title":"Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B450","doi-asserted-by":"crossref","first-page":"367956","DOI":"10.1155\/2013\/367956","article-title":"Expression of SET protein in the ovaries of patients with polycystic ovary syndrome","volume":"2013","author":"Boqun","year":"2013","journal-title":"Int J Endocrinol"},{"key":"2019041121525531100_B451","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1210\/jc.2013-1923","article-title":"Mesenchymal stem\/progenitors and other endometrial Cell types From women With polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential","volume":"98","author":"Piltonen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B452","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1210\/jc.2013-3685","article-title":"A possible new mechanism in the pathophysiology of polycystic ovary syndrome (PCOS): the discovery that leukocyte telomere length is strongly associated with PCOS","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B453","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.2384","article-title":"Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome","volume":"44","author":"Shi","year":"2012","journal-title":"Nat Genet"},{"key":"2019041121525531100_B454","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mce.2012.10.009","article-title":"Genetics of the polycystic ovary syndrome","volume":"373","author":"Kosova","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121525531100_B455","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1210\/jc.2014-2689","article-title":"Further investigation in Europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals","volume":"100","author":"Brower","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B456","doi-asserted-by":"crossref","first-page":"e0126505","DOI":"10.1371\/journal.pone.0126505","article-title":"Association study between polycystic ovarian syndrome and the susceptibility genes polymorphisms in Hui Chinese women","volume":"10","author":"Ha","year":"2015","journal-title":"PLoS One"},{"key":"2019041121525531100_B457","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1038\/ncomms8502","article-title":"A genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat Commun"},{"key":"2019041121525531100_B458","doi-asserted-by":"crossref","first-page":"E1342","DOI":"10.1210\/jc.2011-3478","article-title":"Variants in DENND1A are associated with polycystic ovary syndrome in women of european ancestry","volume":"97","author":"Welt","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B459","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.fertnstert.2015.04.005","article-title":"Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome","volume":"104","author":"Yu","year":"2015","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B460","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mce.2013.01.001","article-title":"The polycystic ovary syndrome and recent human evolution","volume":"373","author":"Corbett","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2019041121525531100_B461","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0031-1275519","article-title":"Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming","volume":"29","author":"Padmanabhan","year":"2011","journal-title":"Semin Reprod Med"},{"key":"2019041121525531100_B462","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0034-1371087","article-title":"Intrauterine environment and polycystic ovary syndrome","volume":"32","author":"Dumesic","year":"2014","journal-title":"Semin Reprod Med"},{"key":"2019041121525531100_B463","first-page":"601","article-title":"Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"81","author":"Ghizzoni","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B464","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.fertnstert.2013.05.023","article-title":"Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood","volume":"100","author":"Abbott","year":"2013","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B465","doi-asserted-by":"crossref","first-page":"e106527","DOI":"10.1371\/journal.pone.0106527","article-title":"Abnormal infant islet morphology precedes insulin resistance in PCOS-Like monkeys","volume":"9","author":"Nicol","year":"2014","journal-title":"PLoS One"},{"key":"2019041121525531100_B466","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.fertnstert.2011.12.028","article-title":"Developmental programming: prenatal testosterone excess disrupts anti-Mullerian hormone expression in preantral and antral follicles","volume":"97","author":"Veiga-Lopez","year":"2012","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B467","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/en.2014-1887","article-title":"Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization","volume":"156","author":"Caldwell","year":"2015","journal-title":"Endocrinology"},{"key":"2019041121525531100_B468","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1210\/en.2010-0666","article-title":"Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues","volume":"151","author":"Nada","year":"2010","journal-title":"Endocrinology"},{"key":"2019041121525531100_B469","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1210\/jcem-39-2-300","article-title":"Androgen formation from pregnenolone sulfate by the human fetal ovary","volume":"39","author":"Payne","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B470","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jcem-47-3-550","article-title":"Conversion of androgen to estrogen by the human fetal ovary","volume":"47","author":"George","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B471","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/edrv-11-4-532","article-title":"Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads","volume":"11","author":"Rabinovici","year":"1990","journal-title":"Endocr Rev"},{"key":"2019041121525531100_B472","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1210\/jc.2006-0641","article-title":"Human fetal ovary development involves the spatiotemporal expression of p450c17 protein","volume":"91","author":"Cole","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B473","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1210\/jc.2010-2618","article-title":"Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary","volume":"96","author":"Fowler","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B474","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0300-595X(78)80005-X","article-title":"Follicular growth in fetal and prepubertal ovaries of humans and other primates","volume":"7","author":"Peters","year":"1978","journal-title":"Clin Endocrinol Metab"},{"key":"2019041121525531100_B475","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1210\/jc.2011-1502","article-title":"Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls","volume":"96","author":"Kuiri-H\u00e4nninen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B476","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2013-1677","article-title":"Postnatal ovarian activation has effects in estrogen target tissues in infant girls","volume":"98","author":"Kuiri-H\u00e4nninen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B477","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1095\/biolreprod28.2.505","article-title":"Estradiol synthesis by fetal monkey ovaries correlates with antral follicle formation","volume":"28","author":"Ellinwood","year":"1983","journal-title":"Biol Reprod"},{"key":"2019041121525531100_B478","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0015-0282(16)44119-1","article-title":"The effect of trophic agents on fetal ovarian steroidogenesis in organ culture","volume":"32","author":"Wilson","year":"1979","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B479","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1210\/jcem-38-4-612","article-title":"Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations","author":"Reyes","year":"1974","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B480","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/jcem-73-3-525","article-title":"Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: circulating levels of gonadotropins, their common \u03b1-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone","volume":"73","author":"Beck-Peccoz","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B481","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1210\/jcem-25-8-1101","article-title":"Steroids and sterols in umbilical cord blood","volume":"25","author":"Eberlein","year":"1965","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B482","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1203\/00006450-199507000-00013","article-title":"17 \u03b1-hydroxyprogesterone, 4-androstenedione, and testosterone profiled by routine stable isotope dilution\/gas chromatography-mass spectrometry in plasma of children","volume":"38","author":"Wudy","year":"1995","journal-title":"Pediatr Res"},{"key":"2019041121525531100_B483","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1210\/jcem-51-4-816","article-title":"Concentration of 14 steroid hormones in human amniotic fluid of midpregnancy","volume":"51","author":"Forest","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B484","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.earlhumdev.2012.08.009","article-title":"Digit ratio (2D:4D) in newborns: influences of prenatal testosterone and maternal environment","volume":"89","author":"Ventura","year":"2013","journal-title":"Early Hum Dev"},{"key":"2019041121525531100_B485","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2015.05.014","article-title":"Measurement of amniotic fluid steroids of midgestation via LC-MS\/MS","volume":"152","author":"Fahlbusch","year":"2015","journal-title":"J Ster Biochem Mol Biol"},{"key":"2019041121525531100_B486","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-15-0699","article-title":"Mass spectrometry methods measured androgen and estrogen concentrations during pregnancy and in newborns of mothers with polycystic ovary syndrome","volume":"174","author":"Caanen","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2019041121525531100_B487","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1210\/jc.2009-2651","article-title":"Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels","volume":"95","author":"Anderson","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B488","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1210\/jc.2009-0544","article-title":"The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study","volume":"94","author":"Hickey","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B489","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejogrb.2012.10.015","article-title":"Placental steroidogenesis in pregnant women with polycystic ovary syndrome","volume":"166","author":"Maliqueo","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121525531100_B490","first-page":"2829","article-title":"Placental characteristics in women with polycystic ovary syndrome","volume":"30","author":"Koster","year":"2015","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B491","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1365-2265.2012.04443.x","article-title":"Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study","volume":"77","author":"Palomba","year":"2012","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B492","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1006\/hbeh.2001.1684","article-title":"Androgens, androgen receptors, and male gender role behavior","volume":"40","author":"Wilson","year":"2001","journal-title":"Horm Behav"},{"key":"2019041121525531100_B493","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1542\/peds.2006-0738","article-title":"Consensus statement on management of intersex disorders. International Consensus Conference on Intersex","volume":"118","author":"Lee","year":"2006","journal-title":"Pediatrics"},{"key":"2019041121525531100_B494","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/00224499.2014.1002124","article-title":"Gender role, gender identity and sexual orientation in CAIS (\u201cXY-women\u201d) compared with subfertile and infertile 46,XX women","volume":"53","author":"Brunner","year":"2016","journal-title":"J Sex Res"},{"key":"2019041121525531100_B495","doi-asserted-by":"crossref","first-page":"e42372","DOI":"10.1371\/journal.pone.0042372","article-title":"Early-to-mid gestation fetal testosterone increases right hand 2D:4D finger length ratio in polycystic ovary syndrome-like monkeys","volume":"7","author":"Abbott","year":"2012","journal-title":"PLoS One"},{"key":"2019041121525531100_B496","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/jc.2015-3926","article-title":"Evidence for increased 5\u03b1-reductase activity during early childhood in daughters of women with polycystic ovary syndrome","volume":"101","author":"Torchen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B497","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/ije\/31.6.1235","article-title":"Fetal origins of adult disease: strength of effects and biological basis","volume":"31","author":"Barker","year":"2002","journal-title":"Int J Epidemiol"},{"key":"2019041121525531100_B498","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1073\/pnas.0806560105","article-title":"Persistent epigenetic differences associated with prenatal exposure to famine in humans","volume":"105","author":"Heijmans","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121525531100_B499","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1210\/jcem.83.10.5205","article-title":"Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism: relation to reduced fetal growth","volume":"83","author":"Ib\u00e1\u00f1ez","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B500","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.metabol.2008.02.018","article-title":"Low birth weight and later development of insulin resistance and biochemical\/clinical features of polycystic ovary syndrome","volume":"57","author":"Pandolfi","year":"2008","journal-title":"Metabolism"},{"key":"2019041121525531100_B501","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/humrep\/deq162","article-title":"High prevalence of polycystic ovary syndrome in women born small for gestational age","volume":"25","author":"Melo","year":"2010","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B502","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/humrep\/des027","article-title":"Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood","volume":"27","author":"Davies","year":"2012","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B503","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(97)06062-5","article-title":"Fetal growth, length of gestation, and polycystic ovaries in adult life","volume":"350","author":"Cresswell","year":"1997","journal-title":"Lancet"},{"key":"2019041121525531100_B504","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.2001.01375.x","article-title":"Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight","volume":"55","author":"Michelmore","year":"2001","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B505","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/humrep\/deg409","article-title":"Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort","volume":"18","author":"Sadrzadeh","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B506","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.ijo.0802301","article-title":"Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms","volume":"27","author":"Laitinen","year":"2003","journal-title":"Int J Obes"},{"key":"2019041121525531100_B507","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/jc.2009-1849","article-title":"Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives","volume":"95","author":"Legro","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B508","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.fertnstert.2014.12.109","article-title":"Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome","volume":"103","author":"Fulghesu","year":"2015","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B509","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2005-2501","article-title":"Controversy in Clin Endocrinol: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria","volume":"91","author":"Franks","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B510","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B511","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"2019041121525531100_B512","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121525531100_B513","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1038\/ijo.2008.247","article-title":"WHO recognition of the global obesity epidemic","volume":"32","author":"James","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"2019041121525531100_B514","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B515","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B516","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol"},{"key":"2019041121525531100_B517","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-3476(87)80522-X","article-title":"Puberty decreases insulin sensitivity","volume":"110","author":"Bloch","year":"1987","journal-title":"J Pediatr"},{"key":"2019041121525531100_B518","first-page":"171","article-title":"Developmental changes in insulin action and secretion in childhood health and disease","volume":"5","author":"Caprio","year":"1994","journal-title":"Adv Endocrinol Metab"},{"key":"2019041121525531100_B519","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1651-2227.1999.tb14410.x","article-title":"Insulin: the other anabolic hormone of puberty","volume":"88","author":"Caprio","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"2019041121525531100_B520","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2337\/diabetes.48.10.2039","article-title":"Insulin resistance during puberty: results from clamp studies in 357 children","volume":"48","author":"Moran","year":"1999","journal-title":"Diabetes"},{"key":"2019041121525531100_B521","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/en.2011-1754","article-title":"Reproductive and metabolic phenotype of a mouse model of PCOS","volume":"153","author":"van Houten","year":"2012","journal-title":"Endocrinology"},{"key":"2019041121525531100_B522","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0015-0282(16)55307-2","article-title":"Puberty and polycystic ovarian syndrome: the insulin\/insulin-like growth factor I hypothesis","volume":"58","author":"Nobels","year":"1992","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B523","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"2019041121525531100_B524","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-09-1102","article-title":"GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome","volume":"163","author":"Chiavaroli","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2019041121525531100_B525","first-page":"1599","article-title":"Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism","volume":"76","author":"Iba\u00f1ez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B526","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/en.2003-0940","article-title":"Valproate potentiates androgen biosynthesis in human ovarian theca cells","volume":"145","author":"Nelson-DeGrave","year":"2004","journal-title":"Endocrinology"},{"key":"2019041121525531100_B527","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.66.66_suppl_3.S23","article-title":"Menstrual disorders in women with epilepsy","volume":"66","author":"Herzog","year":"2006","journal-title":"Neurology"},{"key":"2019041121525531100_B528","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1210\/jc.2010-1658","article-title":"Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS","volume":"96","author":"Kandaraki","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121525531100_B529","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/humrep\/dev123","article-title":"Association of serum levels of typical organic pollutants with polycystic ovary syndrome (PCOS): a case-control study","volume":"30","author":"Yang","year":"2015","journal-title":"Hum Reprod"},{"key":"2019041121525531100_B530","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.fertnstert.2010.09.032","article-title":"Polycystic ovary syndrome: an ancient disorder?","volume":"95","author":"Azziz","year":"2011","journal-title":"Fertil Steril"},{"key":"2019041121525531100_B531","doi-asserted-by":"crossref","first-page":"E2412","DOI":"10.1210\/jc.2014-2703","article-title":"The polycystic ovary syndrome evolutionary paradox: a GWAS-based, in silico, evolutionary explanation","volume":"99","author":"Casarini","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/37\/5\/467\/10492351\/edrv0467.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T09:10:46Z","timestamp":1718701846000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/37\/5\/467\/2567094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":531,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,7,26]]},"published-print":{"date-parts":[[2016,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2015-1104","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]}}}